EP2895484
GLUCOSYLCERAMIDE SYNTHASE INHIBITORS
:
EP einkaleyfi: Þýðing ekki lögð inn:
10.9.2013:
23.2.2022:
13765893.6
:
9.9.2033
:
GLUCOSYLCERAMIDE SYNTHASE INHIBITORS
10.9.2013
23.2.2022
:
Genzyme Corporation:
50 Binney Street, Cambridge, MA 02142, US
:
BOURQUE, Elyse:
Blaine, Washington 98230, US
:
CABRERA-SALAZAR, Mario, A.:
Bridgewater, New Jersey 08807, US
:
CELATKA, Cassandra:
Hull, Massachusetts 02045, US
:
CHENG, Seng, H.:
Bridgewater, New Jersey 08807, US
:
HIRTH, Bradford:
Bridgewater, New Jersey 08807, US
:
GOOD, Andrew:
Bridgewater, New Jersey 08807, US
:
JANCSICS, Katherine:
Wilmington, Massachusetts 01887, US
:
MARSHALL, John:
Bridgewater, New Jersey 08807, US
:
METZ, Markus:
Bridgewater, New Jersey 08807, US
:
SCHEULE, Ronald, K.:
Bridgewater, New Jersey 08807, US
:
SKERLJ, Renato:
Newton, Massachusetts 02465, US
:
XIANG, Yibin:
Acton, Massachusetts 01720, US
:
ZHAO, Zhong:
Bridgewater, New Jersey 08807, US
:
LEONARD, John:
Bridgewater, New Jersey 08807, US
:
NATOLI, Thomas:
Bridgewater, New Jersey 08807, US
:
MAKINO, Elina:
Bridgewater, New Jersey 08807, US
:
HUSSON, Herve:
Bridgewater, New Jersey 08807, US
:
BESKROVNAYA, Oxana:
Bridgewater, New Jersey 08807, US
:
201261699714 P:
11.9.2012:
US
:
US2013058896:
10.9.2013
:
C07D 453/02, A61P 35/00, A61P 25/00, A61K 31/439, C07D 471/08, A61K 31/496, A61K 31/497, A61K 31/506, A61K 31/5377, A61K 31/55, A61K 31/551, A61P 3/00, A61P 9/10, A61P 13/12, A61P 25/16, A61P 25/28, A61P 43/00